Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Lebovitz, Harold E; McFarlane, Samy; Banerji, Mary Ann

doi:10.2337/diacare.21.8.1377

Article navigation

Letters: Comments and Responses| August 01 1998

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Harold E Lebovitz, MD;

Harold E Lebovitz, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Samy McFarlane, MD;

Samy McFarlane, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Mary Ann Banerji, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Harold E. Lebovitz, MD, State University of New York-Health Science Center at Brooklyn, 450 Clarkson Ave., Brooklyn, NY 11203.

Diabetes Care 1998;21(8):1377–1378

https://doi.org/10.2337/diacare.21.8.1377

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio